Efficacy, safety and tolerability of recombinant factor VIII (RE-FA CTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria - Pollmann, H; Externest, D; Ganser, A (Haemophilia, 2007)
et al.